An in vitro study for reducing the cytotoxicity and dose dumping risk of remdesivir via entrapment in nanostructured lipid carriers
Author:
Funder
University of Tehran
Publisher
Springer Science and Business Media LLC
Link
https://www.nature.com/articles/s41598-024-70003-7.pdf
Reference70 articles.
1. Cao, Y.-C., Deng, Q.-X. & Dai, S.-X. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence. Travel Med. Infect. Dis. 35, 101647. https://doi.org/10.1016/j.tmaid.2020.101647 (2020).
2. Wang, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, 269–271. https://doi.org/10.1038/s41422-020-0282-0 (2020).
3. Eastman, R. T. et al. Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19. ACS Cent. Sci 6, 672–683. https://doi.org/10.1021/acscentsci.0c00489 (2020).
4. Gordon, C. J. et al. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J. Biol. Chem. 295, 4773–4779. https://doi.org/10.1074/jbc.AC120.013056 (2020).
5. Adamsick, M. L. et al. Remdesivir in patients with acute or chronic kidney disease and COVID-19. J. Am. Soc. Nephrol. JASN. 31, 1384 (2020).
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3